<DOC>
	<DOCNO>NCT02553889</DOCNO>
	<brief_summary>Evaluation safety , tolerability , PK PD ISIS 416858 patient end-stage renal disease ( ESRD ) receive chronic hemodialysis .</brief_summary>
	<brief_title>A Study Safety , PK , &amp; PD ISIS 416858 Administered Subcutaneously Patients With End-Stage Renal Disease Hemodialysis</brief_title>
	<detailed_description>Evaluation Safety , PK PD ISIS 416858 patient end-stage renal disease ( ESRD ) receive chronic hemodialysis . The overall objective evaluate safety , tolerability , pharmacokinetics , pharmacodynamics ISIS 416858 ESRD patient hemodialysis .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>End stage renal disease maintain outpatient hemodialysis healthcare center &gt; 3 month screen hemodialysis use heparin ( unfractionated heparin lowmolecular weight heparin ) 3 time per week minimum 3 hour per dialysis session plan continue throughout study . Documented thrombotic event ( acute coronary syndrome , stroke transient ischemic attack , venous thromboembolic event ) past 3 month . Active bleeding within past 3 month screen document bleed diathesis ( history bleed disorder ) Screening value : Platelet count &lt; 150,000 cells/mm3 INR &gt; 1.4 aPTT &gt; upper limit normal ( ULN ) Abnormal liver function Screening : ALT AST &gt; 2 x ULN Total bilirubin &gt; ULN Concomitant medication restriction : Concomitant use anticoagulant/antiplatelet agent ( e.g. , dabigatran , rivaroxaban , clopidogrel ) may affect coagulation ( except low dose aspirin ( â‰¤ 100 mg/day ) Treatment Posttreatment Evaluation Periods allow . Uncontrolled hypertension judge Investigator . Patients pre postdialysis blood pressure ( BP ) &gt; 160 mmHg least 3 last 5 dialysis treatment . Planned major surgery next 6 month ( e.g . renal transplant surgery )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>